CPI-613 (Devimistat)
Catalog No. A11786
CPI-613是合成的α-硫辛酸硫辛酸类似物的对映异构体的外消旋混合物,具有潜在的化学预防和抗肿瘤活性。
- Takuji Sakuratani, .et al. Downregulation of ARID1A in gastric cancer cells: a putative protective molecular mechanism against the Harakiri-mediated apoptosis pathway, Virchows Arch, 2020, Aug 13 PMID: 32789692
- Egawa Y, .et al. Therapeutic potential of CPI-613 for targeting tumorous mitochondrial energy metabolism and inhibiting autophagy in clear cell sarcoma, PLoS One, 2018, Jun 7;13(6):e0198940 PMID: 29879220
Catalog Num | A11786 |
---|---|
M. Wt | 388.6 |
Formula | C22H28O2S2 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 95809-78-2 |
Synonyms | CPI613 |
SMILES | C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2 |
CPI-613是合成的α-硫辛酸硫辛酸类似物的对映异构体的外消旋混合物,具有潜在的化学预防和抗肿瘤活性。
Targets
PDH (NCI-H460 cells) | α-ketoglutarate dehydrogenase (NCI-H460 cells) | |||
In vitro (25°C) | DMSO | 74 mg/mL (190.43 mM) | |
Water | Insoluble | ||
Ethanol | 74 mg/mL (190.43 mM) | ||
In vivo | 2% DMSO+corn oil | 13 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 25.73 mL | 128.67 mL | 257.33 mL |
0.5 mM | 5.15 mL | 25.73 mL | 51.47 mL |
1 mM | 2.57 mL | 12.87 mL | 25.73 mL |
5 mM | 0.51 mL | 2.57 mL | 5.15 mL |
*The above data is based on the productmolecular weight 388.6 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.